Andrew D. Seidman
- Oncology top 0.1%
- Pulmonary and Respiratory Medicine top 0.5%
- Cancer Research top 0.5%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Co-authors
- Clifford A. HudisLarry NortonGabriella D’AndreaNancy T. SklarinDeborah KeefeVirginia PatonMary Kathryn PierriPaul Peter Rosen
- Topics
- Cancer Treatment and Pharmacology (135 papers)HER2/EGFR in Cancer Research (88 papers)Breast Cancer Treatment Studies (56 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Andrew D. Seidman
202 papers receiving 10.7k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Oncology 8.1k
- Pulmonary and Respiratory Medicine 2.5k
- Cancer Research 2.2k
- Molecular Biology 2.2k
- Radiology, Nuclear Medicine and Imaging 2.0k
Countries citing papers authored by Andrew D. Seidman
This map shows the geographic impact of Andrew D. Seidman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Seidman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Seidman more than expected).
Fields of papers citing papers by Andrew D. Seidman
This network shows the impact of papers produced by Andrew D. Seidman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Seidman. The network helps show where Andrew D. Seidman may publish in the future.
Co-authorship network of co-authors of Andrew D. Seidman
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Seidman. A scholar is included among the top collaborators of Andrew D. Seidman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Seidman. Andrew D. Seidman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 28 | |
| 6 | 62 | |
| 7 | 35 | |
| 8 | 23 | |
| 9 | 256 | |
| 10 | 11 | |
| 11 | 32 | |
| 12 | 68 | |
| 13 | 446 | |
| 14 | 98 | |
| 15 | 10 | |
| 16 | Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. | 229 |
| 17 | 9 | |
| 18 | HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications. | 136 |
| 19 | Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.breakdown → | 1088 |
| 20 | 138 |
About Andrew D. Seidman
Andrew D. Seidman is a scholar working on Oncology, Cancer Research and Dermatology, having authored 211 papers that have together received 11.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (135 papers), HER2/EGFR in Cancer Research (88 papers) and Breast Cancer Treatment Studies (56 papers). The work is most often cited by research in Oncology (8.1k citations), Cancer Research (2.2k citations) and Radiology, Nuclear Medicine and Imaging (2.0k citations). Andrew D. Seidman has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Clifford A. Hudis, Larry Norton, Gabriella D’Andrea, Nancy T. Sklarin, Deborah Keefe, Virginia Paton, Mary Kathryn Pierri, Paul Peter Rosen, José Baselga and Maureen Murphy. Their work appears in journals such as Journal of Clinical Oncology, Neurology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.